The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

 

The pharmaceutical suppositories market has shown strong growth in recent years and continues to expand. This blog explores the market’s current state, drivers of growth, major players, and emerging trends that are shaping its future.

 

Market Growth Overview

Recent Growth

• 2023 to 2024:
  • The market grew from $1.6 billion in 2023 to $1.7 billion in 2024, at a compound annual growth rate (CAGR) of 6.3%.
  • Key drivers include increased healthcare expenditure, new regulatory approvals, government initiatives, rising prevalence of constipation, and the increasing prevalence of diseases.

 

Future Projections

• 2024 to 2028:
  • The market is expected to grow to $2.19 billion by 2028, with a CAGR of 6.5%.
  • Future growth will be driven by an increase in the prevalence of kidney damage or failure and hemorrhoids.

 

Read The Full Microgrid Monitoring Market Report Here:
https://www.thebusinessresearchcompany.com/report/microgrid-monitoring-global-market-report

 

Catalyst for Pharmaceutical Suppositories Market Growth

Increasing Prevalence of Diseases

• Factors Contributing to Disease Prevalence:
  • Geology and climate.
  • Insects that transmit diseases.
  • Aging population and lifestyle factors.
• Role of Suppositories:
  • Effective drug delivery method, particularly for conditions that require targeted treatment.
  • Useful for patients with specific diseases and those unable to take oral medications.
• Case Example:
  • According to the Australian Institute of Health and Welfare, over 4,700 hospitalizations were reported with COVID-19 in 2020–2021, highlighting the need for diverse treatment methods including suppositories.

 

Major Players in the Market

Key Companies

• Prominent Companies:
  • Bayer AG, Pfizer Inc., Novartis International AG, Sanofi S.A., Intas Pharmaceuticals Ltd.
  • Others include Unither Pharmaceuticals, Cosette Pharmaceuticals, Aenova Holding GmbH, Delpharm, and Bliss GVS Pharma Ltd.

 

Transforming the Pharmaceutical Suppositories Market

Technological Advancements

• Embracing New Technologies:
  • Companies are leveraging advanced technologies to improve product effectiveness and patient convenience.
  • Example: In March 2021, CB21 Pharma launched CANNEFF VAG SUP vaginal suppositories and CANNEFF SUP rectal suppositories, addressing specific medical conditions with innovative formulations.

 

Product Innovations

• Focus on Patient Convenience:
  • Innovations in formulation and delivery methods to enhance patient adherence.
  • Development of suppositories that are easier to administer and more effective in delivering medication.

 

Strategic Acquisitions

Merck & Co. Acquisition

• Notable Acquisition:
  • In April 2023, Merck & Co. acquired Prometheus Biosciences for $10.8 billion.
  • This acquisition aims to advance treatments for ulcerative colitis and Crohn’s disease through monoclonal antibody therapy delivered via suppositories.

 

Market Segmentation

By Type

• Segments:
  • Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories, Other Types.

By Base

• Bases:
  • Fatty Base, Water Miscible Bases, Emulsifying Bases.

By End-User

• End-Users:
  • Hospitals and Clinics, Nursing Homes, Home Care, Other End Users.

 

Regional Insights

Current Leaders

• North America:
  • The largest region in the pharmaceutical suppositories market in 2023, driven by high healthcare expenditure and advanced healthcare infrastructure.

Fastest Growing

• Asia-Pacific:
  • Expected to be the fastest-growing region during the forecast period, attributed to increasing healthcare awareness and economic growth.

 

Conclusion
The pharmaceutical suppositories market is poised for continued growth, driven by the increasing prevalence of diseases, technological advancements, and strategic industry acquisitions. As healthcare needs evolve, suppositories will remain a crucial drug delivery method, offering effective treatment options for a variety of conditions.

 

Get A Free Sample On The Global Microgrid Monitoring Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=14752&type=smp

 

The Microgrid Monitoring Global Market Report 2024  provides an overview of the microgrid monitoring market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The microgrid monitoring market forecast analyzes microgrid monitoring market size, microgrid monitoring market share, leading competitor and their market positions.

 

Explore Similar Reports From The Business Research Company: Microgrid Controller Global Market Report 2024
Microgrid-As-A-Service Global Market Report 2024
Respiratory Monitoring Devices Global Market Report 2024

 

Learn More About The Business Research Company
The Business Research Company has published over 6500+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

 

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

 

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: